R3 Vascular Inc.
PrivateLast Round
Series B
May 9, 2024
Est. Valuation
$145M
Total Funding Raised
$104.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
R3 Vascular Inc. is a medical device company that develops bioresorbable, sirolimus-coated vascular scaffolds for the treatment of peripheral arterial disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
R3 Vascular Inc. Comparables
Compare R3 Vascular Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| REVA Medical | 89% | |
| STENTiT | 85% | |
| Zorion Medical | 84% |
R3 Vascular Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 9, 2024 | ||||
| Series A | Oct 8, 2020 |
R3 Vascular Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B |
| 415 | Series A, Series B |
| 415 Capital | Series B, Series A |
| Wexford Capital | Series A |
| HBM Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2026
Grew 18% QoQ, from 28 to 33 employees.
- Oct 8, 2020
$18M round led by 415 Capital
Recent news
Latest coverage and updates
- hiresSep 21, 2026
R3 Vascular Inc. hired Lisa Wipperman Heine as Board of Directors on Sep 21st '26.
- hiresSep 21, 2026
R3 Vascular Inc. hired Lisa as Board of Directors on Sep 21st '26.
- hiresAug 24, 2026
R 3 Vascular Inc. hired Robert Spanos as Vice President, Global Market Development on Aug 24th '26.
- hiresAug 24, 2026
R3 Vascular Inc. hired Katie Segreto as Vice President, Finance and Corporate Controller on Aug 24th '26.
- hiresAug 24, 2026
R3 Vascular Inc. hired Robert Spanos as Vice President, Global Market Development on Aug 24th '26.
R3 Vascular Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about R3 Vascular Inc.'s valuation, stock price, and market status.
Is R3 Vascular a public or private company?
R3 Vascular is a private company.
What is the current stock price of R3 Vascular?
R3 Vascular is a private company with no public stock price. No recent secondary market data is available.
How much is R3 Vascular worth (valuation)?
Valuation information for R3 Vascular is not publicly available.
Can I buy R3 Vascular stock?
R3 Vascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was R3 Vascular's last funding round?
R3 Vascular's most recent funding round was Series B on May 9, 2024.
Who are the main investors in R3 Vascular?
Key investors in R3 Vascular include Deerfield Management, 415, 415 Capital.
Will R3 Vascular IPO soon?
No public IPO plans have been announced for R3 Vascular.
How can I track R3 Vascular secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor R3 Vascular's secondary market activity and sign up for updates.